- Home
- HBNC vs IART Comparison
HBNC vs IART Comparison
Compare HBNC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBNC | IART |
|---|---|---|
| Founded | 1873 | 1989 |
| Country | United States | United States |
| Employees | N/A | 4427 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 944.0M | 1.2B |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | HBNC | IART |
|---|---|---|
| Price | $18.33 | $15.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $21.00 | $14.33 |
| AVG Volume (30 Days) | 232.9K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | $5.52 | $3.40 |
| P/E Ratio | $36.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.38 | $8.70 |
| 52 Week High | $19.07 | $16.42 |
Technical Indicators
Market Signals| Indicator | HBNC | IART |
|---|---|---|
| Relative Strength Index (RSI) | 57.81 | 70.06 |
| Support Level | $17.18 | $12.64 |
| Resistance Level | $18.73 | $16.35 |
| Average True Range (ATR) | 0.44 | 0.91 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 72.85 | 90.11 |
Price Performance
Historical ComparisonAbout HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.